Business
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the American
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":" CHICAGO--(BUSINESS WIRE)--\nGE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the American Society for Radiation Oncology (ASTRO) 2024 conference in Washington, DC. These novel solutions aim to improve the entirety of the radiation therapy workflow for clinicians and cancer patients.\n\nIt is estimated that 470,000 patients receive radiotherapy each year in the U.S. and more than half of patients with cancer will receive radiotherapy.i The silver lining is, that in recent years, improvements in diagnosis, therapy, and supportive care have led to increasing numbers of cancer survivors.i The innovations showcased at ASTRO are helping clinicians more efficiently navigate the complex oncology care pathway, ultimately enabling truncated timelines from diagnosis to treatment, which are critical for improved patient outcomes.\n\nGE HealthCare will be showcasing the following radiation oncology solutions at ASTRO 2024:\n\n\nIntelligent Radiation Therapy (iRT): Designed to enable multi-vendor system interoperability, connectivity, and efficiency throughout the radiation oncology care continuum. The artificial intelligence (AI)-enhanced iRT includes key features such as an integrated workflow that connects hardware and software vendors, as well as various applications, into an intuitive single interface.\n\n\nRevolution™ RT: Recently introduced at ESTRO, this new system enables precision radiation therapy simulation and includes a wide-bore CT (computed tomography) platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities. The technology’s capabilities are now further enhanced with GE HealthCare’s MIM Software solutions.\n\n\nMIM Maestro and Contour ProtégéAI+: A range of interoperable technologies from GE HealthCare’s MIM Software (acquired in April 2024), including Contour ProtégéAI+ for zero-click AI auto-contouring and MIM Maestro for easier reirradiation, faster simulation-to-treatment times, and better target volumes.\n\n\nProstate Volume Assist: AI software available on ultrasound-guided active imaging systems designed to automate the process for generating prostate volume measurements.\n\n\nStarGuide™: A digital SPECT (Single Photon Emission Computed Tomography)/CT offering clinicians unique opportunities to make person...